ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium glycerophosphate hydrate, quantity: 6.122 g (equivalent: sodium glycerophosphate, qty 4.32 g) - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections - glycophos? is indicated in adult and paediatric patients as a supplement to parenteral nutrition to meet the daily requirements of phosphate.

อิสราเอล - อังกฤษ - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of adult and paediatric patients ≥2 months of age with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

อิสราเอล - อังกฤษ - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of adult and paediatric patients ≥2 months of age with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

อิสราเอล - อังกฤษ - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of adult and paediatric patients ≥2 months of age with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

อิสราเอล - อังกฤษ - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate synthetase i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

อิสราเอล - อังกฤษ - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate synthetase i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

อิสราเอล - อังกฤษ - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate synthetase i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

มาเลเซีย - อังกฤษ - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - secukinumab -

ญี่ปุ่น - อังกฤษ - すりの適正使用協議会 RAD-AR Council, Japan

ohsugi pharmaceutical co.,ltd. - hangekobokuto - grayish brown fine granules

ญี่ปุ่น - อังกฤษ - すりの適正使用協議会 RAD-AR Council, Japan

kracie pharmaceutical.ltd. - hangekobokuto - light brown to brown granules